Drug repositioning candidates identified using in-silico quasi-quantum molecular simulation demonstrate reduced COVID-19 mortality in 1.5M patient records

Joy Alamgir, Masanao Yajima, Rosa Ergas, Xinci Chen, Nicholas Hill, Naved Munir, Mohsan Saeed, Ken Gersing, Melissa Haendel, Christopher G Chute, M. Ruhul Abid
doi: https://doi.org/10.1101/2021.03.22.21254110

Article Information

doi 
https://doi.org/10.1101/2021.03.22.21254110
History 
  • April 6, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Joy Alamgir1,*,
  2. Masanao Yajima, PhD2,
  3. Rosa Ergas, MPH1,
  4. Xinci Chen, MSc1,
  5. Nicholas Hill, MPH3,
  6. Naved Munir, MD, MSc4,
  7. Mohsan Saeed, PhD5,
  8. Ken Gersing, MD6,
  9. Melissa Haendel, PhD7,
  10. Christopher G Chute, MD DrPH8 and
  11. M. Ruhul Abid, MD, PhD9
  1. 1ARIScience
  2. 2Boston University, Department of Mathematics and Statistics
  3. 3Great Plains Tribal Leader’s Health Board
  4. 4Caromont Regional Medical Center
  5. 5Boston University
  6. 6National Institutes of Health
  7. 7Oregon Health & Science University
  8. 8Johns Hopkins University
  9. 9Brown University,
  1. ↵*Corresponding author; email: joy{at}ariscience.com
Back to top
Posted April 06, 2021.
Download PDF
Data/Code
Email
Drug repositioning candidates identified using in-silico quasi-quantum molecular simulation demonstrate reduced COVID-19 mortality in 1.5M patient records
Joy Alamgir, Masanao Yajima, Rosa Ergas, Xinci Chen, Nicholas Hill, Naved Munir, Mohsan Saeed, Ken Gersing, Melissa Haendel, Christopher G Chute, M. Ruhul Abid
medRxiv 2021.03.22.21254110; doi: https://doi.org/10.1101/2021.03.22.21254110
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area